Here is What Hedge Funds Think About Tesaro Inc (TSRO)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Posts Tagged ‘NASDAQ:TSRO’
Hedge Fund and Insider Trading News: Philip Falcone, Ray Dalio, Continental Resources, Inc. (CLR), Sandy Spring Bancorp Inc. (SASR), Independent Bank Group Inc (IBTX), and More
Hedge Funder Phil Falcone Just Listed his New York City Townhouse for $39 Million (Business Insider) Philip Falcone is ready for a bigger house.
Hedge Fund and Insider Trading News: Kyle Bass, Corvex Management, Citadel Investment Group, WisdomTree Investments, Inc. (WETF), Zoe’s Kitchen Inc (ZOES), TESARO Inc (TSRO), and More
Kyle Bass: Broadcom-Qualcomm Deal Shouldn't be Allowed to Go Through (CNBC) Hedge fund manager Kyle Bass said possible U.S.
Here’s Why TESARO Inc (TSRO) Fell Sharply
Shares of TESARO Inc (NASDAQ:TSRO) are off almost 10% in afternoon trading on Thursday after the company announced the wholesale cost of 30 pills of ZEJULA 200mg at around $9833...
Financial Markets Snapshot: 20+ Stories That You Should Read Today
1. US Stock Market: "U.S.
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors.
Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ...
The Three Most Important Questions For TESARO Inc (TSRO) Shareholders Right Now
TESARO Inc (NASDAQ:TSRO) took a bit of a hit early Thursday morning, as the FDA announced it had issued a complete response letter (CRL) to the company relating to its latest ...
What We’re Watching In Biotech For January: Otonomy Inc (OTIC) And TESARO Inc (TSRO)
It’s going to be a busy month in the biotechnology sector.
Do Hedge Funds Love TESARO Inc (TSRO)?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions...
Here’s Another Discount Entry Opportunity: TESARO Inc (TSRO)
TESARO Inc (NASDAQ:TSRO) just announced an equity offering, and the company has taken a considerable hit as a result.
Trending Stocks: TESARO, American Airlines, Delta, and More
The S&P 500 and NASDAQ index both opened in the green today after retail sales for October came in ahead of expectations.
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns
Bihua Chen's Cormorant Asset Management is one of some 750 investors that we track and whose quarterly 13F filings we analyze to identify stocks that they are collectively bullish...
Here’s Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today
Climbing oil prices and polls suggesting Hillary Clinton’s success in the second presidential debate are favoring the market sentiment on Monday, as all three indices are trading...
Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data
TESARO Inc (NASDAQ:TSRO) just announced that the FDA has granted Fast Track designation to its lead ovarian, fallopian tube, or primary peritoneal cancer candidate, and that on...
Here’s Why Many Smart Money Investors Are Bullish on Clovis Oncology
Clovis Oncology Inc (NASDAQ:CLVS) is a biopharmaceutical company focused on developing and commercializing anti-cancer agents.
Here’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks
Stocks are trading in the green on Thursday as markets continue to steadily recover from the Brexit-triggered wild swings.
Here’s Why These Five Stocks Are On the Move on Wednesday
On the second to last day before the end of the quarter, all three indexes and crude futures are higher.
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Do Hedge Funds Love TESARO Inc (TSRO)?
Before we spend many hours researching a company, we'd like to analyze what hedge funds and billionaire investors think of the stock first.
Sientra Inc (SIEN), TESARO Inc (TSRO) and Clovis Oncology Inc (CLVS): Orbimed’s Top New Picks
Samuel Islay's Orbimed Advisors has revealed its equity portfolio as of end of 2014, in a recent filing with the Securities and Exchange Commission.
Biogen Idec Inc (BIIB) & TESARO Inc (TSRO): Top Biotech Stocks from Robyn Karnauskas Of Deutsche Bank
In the back drop of the biotech S&P ETF impacted by the S&P shedding market valuation by close to 7 % this week, Robyn Karnauskas who heads Deutsche Bank’s biotechnology vertical...
Insider Watch: 5 Stocks Scott D. Sandell Likes
Scott Sandell, a large shareholder and director with over 30 affiliations is the insider to watch for retail investors. He is the general partner of New Enterprise Associates.
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
What's a smart Dendreon Corporation (NASDAQ:DNDN) investor to do? To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc.
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
What's a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Idenix Pharmaceuticals Inc (IDIX), GenMark Diagnostics, Inc (GNMK): Horrendous Health-Care Stocks This Week
The overall markets experienced the biggest one-day losses in quite a while this week. But those drops were pocket change compared with these horrendous health-care stocks.
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Three Humongous Health-Care Stocks This Week
Summer doesn't officially arrive for a few more weeks, but the first week of June packed some real heat.
Dendreon Corporation (DNDN): Are Hedge Funds Right About This Stock?
Dendreon Corporation (NASDAQ:DNDN) was in 13 hedge funds' portfolio at the end of March.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
Halozyme Therapeutics, Inc. (NASDAQ:HALO) has seen an increase in activity from the world's largest hedge funds lately.
Clovis Oncology Inc (CLVS): Double Data, Double Stock Price
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology Inc (NASDAQ:CLVS) ...
Ambarella Inc (AMBA), Chuy’s Holdings Inc (CHUY): Are These Top Post-IPO Performers Still a Buy?
Investors are no stranger to large IPO pops, but in the last year we have seen incredible post-IPO runs, indicating that these companies were priced too cheap.
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
Is Clovis Oncology Inc (CLVS) Going to Burn These Hedge Funds?
Is Clovis Oncology Inc (NASDAQ:CLVS) the right investment to pursue these days? The best stock pickers are taking a pessimistic view.
Hedge Fund Resource Center
